MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 27338043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study on the relationship between miR-520g and the development of breast cancer.

  2016cited by this paper
• Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143.

  2015cited by this paper
• Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43.

  2015cited by this paper
• The fate of chemoresistance in triple negative breast cancer (TNBC)

  2015cited by this paper
• BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers

  2015cited by this paper
• MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer

  2015cited by this paper
• Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer

  2015cited by this paper
• Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p

  2014cited by this paper
• Screening miRNAs related to different subtypes of breast cancer with miRNAs microarray.

  2014cited by this paper
• The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

  2014cited by this paper
• MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer

  2014cited by this paper
• Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers

  2014cited by this paper
• Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells.

  2014cited by this paper
• Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1

  2014cited by this paper
• miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

  2013cited by this paper
• Loss of Dicer expression is associated with breast cancer progression and recurrence

  2012cited by this paper
• Expression of Dicer and Drosha in triple-negative breast cancer

  2012cited by this paper
• Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

  2011cited by this paper
• miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase

  2011cited by this paper
• microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.

  2011cited by this paper
• Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.

  2011cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• The role of SRC-3 in human breast cancer

  2010cited by this paper
• Triple-negative breast cancer.

  2008cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  2003cited by this paper
• Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.

  2000cited by this paper
• Cancer statistics

  1989cited by this paper

• MicroRNA-driven organ-specific metastasis in triple-negative breast cancer: biogenesis, mechanisms, and therapeutic approaches

  2025cites this paper
• Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

  2025cites this paper
• Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer

  2024cites this paper
• Role of miRNAs in breast cancer development and progression: Current research

  2024cites this paper
• Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer

  2024cites this paper
• Protective effect of miR‐18a in resected liver metastases of colorectal cancer and FOLFOX treatment

  2023cites this paper
• Breast cancer: miRNAs monitoring chemoresistance and systemic therapy

  2023cites this paper
• Non-coding RNA’s prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer

  2023cites this paper
• Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review.

  2023cites this paper
• Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy

  2023cites this paper
• Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

  2023cites this paper
• miRNAs in the prognosis of triple-negative breast cancer: A review.

  2023cites this paper
• Inhibition of FOXO1-mediated autophagy promotes paclitaxel-induced apoptosis of MDA-MB-231 cells

  2022cites this paper
• siRNA targeting ABCB1 potentiates the efficacy of chemotherapy in human triple-negative breast cancer cells

  2022cites this paper
• Acquisition of hybrid E/M phenotype associated with increased migration, drug resistance and stemness is mediated by reduced miR-18a levels in ER-negative breast cancer

  2022cites this paper
• miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis

  2022cites this paper
• Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

  2022cites this paper
• Methods for predicting single-cell miRNA in breast cancer.

  2022cites this paper
• The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer

  2022cites this paper
• Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications

  2022cites this paper
• Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC

  2022cites this paper
• Inhibition of FOXO 1 ‐ mediated autophagy promotes paclitaxel ‐ induced apoptosis of MDA ‐ MB ‐ 231 cells

  2022cites this paper
• Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer

  2021cites this paper
• RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.

  2021cites this paper
• Inhibition of FOXO1-Mediated Autophagy Promotes Paclitaxel-Induced Apoptosis in MDA-MB-231 Cell Lines

  2021cites this paper
• MicroRNA Expression Profiles and Breast Cancer Chemotherapy

  2021cites this paper
• Regulatory MicroRNAs in T2DM and Breast Cancer

  2021cites this paper
• DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p.

  2021cites this paper
• The Role of Non-Coding RNAs in Breast Cancer Drug Resistance

  2021cites this paper
• Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway

  2021cites this paper
• Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

  2021influential citation
• Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.

  2021cites this paper
• A Compressive Review about Taxol®: History and Future Challenges

  2020cites this paper
• Systematic characterization of non‐coding RNAs in triple‐negative breast cancer

  2020cites this paper
• ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.

  2020cites this paper
• miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis

  2020cites this paper
• Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.

  2020cites this paper
• Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer

  2020cites this paper
• Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer

  2020cites this paper
• Mechanisms of Taxane Resistance

  2020influential citation
• Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.

  2020cites this paper
• Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis

  2019cites this paper
• Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy

  2019cites this paper
• Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

  2019cites this paper
• MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition

  2019cites this paper
• MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer

  2019cites this paper
• miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance

  2019cites this paper
• MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration

  2018cites this paper
• The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs

  2018cites this paper
• Biomarker-Based Targeted Therapeutics

  2018cites this paper
• Key microRNAs in the biology of breast cancer; emerging evidence in the last decade

  2018cites this paper
• MicroRNA-18a Expression in Female Coronary Heart Disease and Regulatory Mechanism on Endothelial Cell by Targeting Estrogen Receptor

  2018cites this paper
• MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.

  2018cites this paper
• Dicer affects cisplatin-mediated apoptosis in epithelial ovarian cancer cells

  2018cites this paper
• Molecular pathways involved in microRNA-mediated regulation of multidrug resistance

  2018cites this paper
• Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1

  2018cites this paper
• The correlation of circulating pro‐angiogenic miRNAs’ expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer

  2018cites this paper
• New emerging roles of microRNAs in breast cancer

  2018cites this paper
• Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications

  2017cites this paper
• Role of MIR-29B-1 and MIR-29A in endocrine-resistant breast cancer.

  2017cites this paper
• MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.

  2017cites this paper
• Anti-proliferative effect of digoxin on breast cancer cells via inducing apoptosis.

  2017cites this paper
• The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients.

  2017cites this paper
• MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.

  2017cites this paper
• Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

  2017cites this paper
• MicroRNAs in prostate cancer: Functional role as biomarkers.

  2017cites this paper
• Overexpression of microRNA-365 inhibits breast cancer cell growth and chemo-resistance through GALNT4.

  2016cites this paper